RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

Bollinger Motors today announced it has emerged from receivership as its parent company Mullen Automotive Inc. , an electric vehicle manufacturer, settled claims in a lawsuit filed by Bollinger Motors ...

While most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many ...

After years of U.S. stock-market gains, investment experts see more value abroad. One recommendation: 15% to 20% in foreign markets.

The reverse stock split is intended to increase the market price per share of the Company’s common stock and help the Company satisfy the initial listing requirements of the New York Stock Excha ...

QVC Group is taking several steps to avoid being delisted from Nasdaq. Shareholders this week approved a reverse stock split at a ratio of 1-for-50, according to a Friday press release.

Today the Company announced that, subject to stockholder approval of the Reverse Stock Split Proposal at the Special Meeting, the Company will effect a 1-for-15 reverse stock split of the Company ...

Ekso Bionics will implement a 1-for-15 reverse stock split effective May 27, 2025, to improve its stock price compliance. Ekso Bionics Holdings, Inc., a developer of exoskeletons for medical and ...

Conduit Pharmaceuticals Inc. announced a 1-for-15 reverse stock split of its common stock, approved by its board and stockholders, effective May 19, 2025. Following this split, every fifteen ...

SAN RAFAEL, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today ...

As a result of the Reverse Stock Split, the Company’s common stock is expected to begin trading on a split-adjusted basis when the markets open on June 3, 2025. As a result of the Reverse Stock ...

The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on June 2, 2025, and Applied DNA common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market ...